Rie Furuta

493 total citations
10 papers, 365 citations indexed

About

Rie Furuta is a scholar working on Immunology, Agronomy and Crop Science and Infectious Diseases. According to data from OpenAlex, Rie Furuta has authored 10 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Agronomy and Crop Science and 3 papers in Infectious Diseases. Recurrent topics in Rie Furuta's work include T-cell and Retrovirus Studies (6 papers), Animal Disease Management and Epidemiology (5 papers) and HIV Research and Treatment (3 papers). Rie Furuta is often cited by papers focused on T-cell and Retrovirus Studies (6 papers), Animal Disease Management and Epidemiology (5 papers) and HIV Research and Treatment (3 papers). Rie Furuta collaborates with scholars based in Japan, United Kingdom and United States. Rie Furuta's co-authors include Masao Matsuoka, Jun‐ichirou Yasunaga, Yuichi Mitobe, Satoshi Kubota, Masakazu Hatanaka, M. Maki, Kenji Sugata, Mohamed Mahgoub, Liping Duan and Tomoo Sato and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer Research.

In The Last Decade

Rie Furuta

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rie Furuta Japan	7	280	198	193	77	54	10	365
Guangyong Ma Japan	10	318 1.1×	263 1.3×	252 1.3×	76 1.0×	29 0.5×	16	417
Andrea K. Thoma‐Kress Germany	13	323 1.2×	219 1.1×	197 1.0×	116 1.5×	48 0.9×	29	472
Claire Guillerm France	7	197 0.7×	118 0.6×	123 0.6×	110 1.4×	24 0.4×	7	372
Estelle Chiari United States	8	231 0.8×	151 0.8×	142 0.7×	167 2.2×	15 0.3×	10	393
M C Dokhélar France	9	307 1.1×	170 0.9×	165 0.9×	78 1.0×	146 2.7×	11	460
S M Pettiford United States	9	256 0.9×	167 0.8×	174 0.9×	145 1.9×	18 0.3×	9	401
Aviva Witkover United Kingdom	13	593 2.1×	450 2.3×	385 2.0×	62 0.8×	28 0.5×	16	673
Amane Sasada Japan	7	284 1.0×	154 0.8×	149 0.8×	99 1.3×	155 2.9×	12	429
Ester Teresa González Argentina	9	196 0.7×	190 1.0×	147 0.8×	34 0.4×	23 0.4×	19	335
R. Kettmann Belgium	7	283 1.0×	224 1.1×	187 1.0×	70 0.9×	25 0.5×	12	332

Countries citing papers authored by Rie Furuta

Since Specialization

Citations

This map shows the geographic impact of Rie Furuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rie Furuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rie Furuta more than expected).

Fields of papers citing papers by Rie Furuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rie Furuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rie Furuta. The network helps show where Rie Furuta may publish in the future.

Co-authorship network of co-authors of Rie Furuta

This figure shows the co-authorship network connecting the top 25 collaborators of Rie Furuta. A scholar is included among the top collaborators of Rie Furuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rie Furuta. Rie Furuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Furuta, Rie & Ayumi Miyake. (2025). Fibroblast growth factor 22. Differentiation. 143. 100860–100860. 1 indexed citations

Sato, Tomoo, Ariella Coler‐Reilly, Naoko Yagishita, et al.. (2018). Mogamulizumab (Anti-CCR4) in HTLV-1–Associated Myelopathy. New England Journal of Medicine. 378(6). 529–538. 72 indexed citations

Furuta, Rie, Jun‐ichirou Yasunaga, Michi Miura, et al.. (2017). Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathogens. 13(11). e1006722–e1006722. 68 indexed citations

Sugata, Kenji, Jun‐ichirou Yasunaga, Yuichi Mitobe, et al.. (2016). HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation. Cancer Research. 76(17). 5068–5079. 55 indexed citations

Yasunaga, Jun‐ichirou, Rie Furuta, Michi Miura, et al.. (2016). Hematopoietic Stem Cell Infected with HTLV-1 Functions As a Viral Reservoir In Vivo. Blood. 128(22). 1343–1343. 6 indexed citations

Mitobe, Yuichi, Jun‐ichirou Yasunaga, Rie Furuta, & Masao Matsuoka. (2015). HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival. Cancer Research. 75(19). 4143–4152. 72 indexed citations

Kubota, Satoshi, Liping Duan, Rie Furuta, Masakazu Hatanaka, & Roger J. Pomerantz. (1996). Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein. Journal of Virology. 70(2). 1282–1287. 29 indexed citations

Furuta, Rie, et al.. (1995). Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. Journal of Virology. 69(3). 1591–1599. 25 indexed citations

Kubota, Satoshi, Rie Furuta, M. Maki, Haruhiko Siomi, & Masakazu Hatanaka. (1993). Long cellular repeats flanking a defective HTLV-I provirus: implication for site-targeted integration.. PubMed. 8(10). 2873–7. 6 indexed citations

10.

Kubota, Satoshi, Rie Furuta, M. Maki, & Masakazu Hatanaka. (1992). Inhibition of human immunodeficiency virus type 1 Rev function by a Rev mutant which interferes with nuclear/nucleolar localization of Rev. Journal of Virology. 66(4). 2510–2513. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact